New vaccine should ease meningitis fears.

摘要: THE RECENT LICENSING OF A NEW meningococcal conjugate vaccine has prompted government officials to expand recommended immunization practices. The new is expected drastically reduce the prevalence of invasive disease caused by Neisseria meningitidis serogroups C Y and W-135 which make up majority cases in United States. Advisory Committee on Immunization Practices Centers for Disease Control Prevention (CDC) February 10 that children aged 11 12 years teens entering high school college freshman living dormitories receive (groups W-135) polysaccharide diphtheria toxoid (Menactra). This manufactured Sanofi Pasteur (Swiftwater Pa) received US Food Drug Administration approval January 14 2005. (excerpt)